2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income - EUR | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Expenses - EUR | 2.111 | 112 | 184 | 132 | 137 | 48 | 0 | 0 | 0 | 0 |
Gross Profit/Loss - EUR | -2.083 | -112 | -184 | -132 | -137 | -48 | 0 | 0 | 0 | 0 |
Net Profit/Loss - EUR | -2.083 | -112 | -184 | -132 | -137 | -48 | 0 | 0 | 0 | 0 |
Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Red Shield Pharma S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 31.907 | 23.832 | 3.340 | 3.151 | 2.956 | 2.850 | 2.796 | 2.734 | 2.743 | 2.734 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 28.976 | 20.313 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 2.932 | 3.519 | 3.340 | 3.151 | 2.956 | 2.850 | 2.796 | 2.734 | 2.743 | 2.734 |
Shareholders Funds | -10.637 | -10.839 | -10.912 | -10.860 | -10.798 | -10.637 | -10.435 | -10.204 | -10.235 | -10.204 |
Social Capital | 49 | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 |
Debts | 42.545 | 34.670 | 14.252 | 14.011 | 13.754 | 13.487 | 13.231 | 12.938 | 12.978 | 12.939 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4646 - 4646" | |||||||||
CAEN Financial Year | 4646 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.